[Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
D000284:Administration, Oral; D000368:Aged; D000547:Amantadine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002214:Capsules; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006851:Hydrochloric Acid; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D011581:Psychological Tests
D002214:Capsules; D010276:Parasympatholytics; D000547:Amantadine; D006851:Hydrochloric Acid
Behandlungsergebnis mit Amantadin-Hydrochlorid beim Parkinson-Syndrom unter Verwendung testpsychologischer Untersuchungsmethoden. (Vorläufige Mitteilung)